About Celystra Pharma
Démystifier la vie à l’échelle cellulaire | Illuminating life at the cellular level
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Montréal, Québec
- Founded
- 2026
- Company type
- Privately Held
𝗖𝗲𝗹𝘆𝘀𝘁𝗿𝗮 𝗣𝗵𝗮𝗿𝗺𝗮 is a Quebec-based biopharmaceutical company specializing in the introduction of innovative treatments to Canada.
Founded by three pharmaceutical industry veterans, the company identifies and acquires innovative therapies developed internationally and brings them to underserved patient populations in Canada.
Based in Montreal and active within Quebec’s life sciences ecosystem, 𝗖𝗲𝗹𝘆𝘀𝘁𝗿𝗮 𝗣𝗵𝗮𝗿𝗺𝗮 works with global partners to help bring new treatments to patients who need them.
With bold science, disciplined execution, and an unwavering focus on patients, we are building a future where breakthrough therapies don’t just advance medicine - they restore possibility.
Specialties
- Rare Disease
- Specialty Medicines
- Innovative Therapies
- Canadian Distributor
- Orphan Drugs
- Partnerships
- Market Access
- Health Thecnology Assessment
- Biopharmaceutical company
- Rare genetic disorders
- Familial Chylomicronemia Syndrome (FCS)
- Severe Hypertriglyceridemia (sHTG)
- Tryngolza – olezarsen injection
- Hereditary angioedema (HAE)
- Dawnzera – donidalorsen
- and IONIS partner
Company locations
3650 Rue Saint‑Urbain, Suite 727, Montréal, Québec H2X 2L5, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
On LinkedIn
- Followers
- 1,126
- People linked to this company
- 21
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.